EGM Scrutinizer''s Report
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Drugs Limited held an Extra-Ordinary General Meeting on 26 December 2025 in Indore, and all five resolutions were passed with the required majority. Two new Non-Executive Independent Directors, Ms. Ritu Tiwari (DIN: 11040362) and Ms. Nikita Sinha (DIN: 11126745), were appointed with 100% votes in favour (51 members, 20,84,647 shares). The remuneration of Mr. Kuniamuthur Nanjappan Anand was revised with 99.9988% approval (only 11 shares voted against); his own 6,58,500 shares were declared invalid because he is interested in that resolution. Approval to give loans, guarantees and make investments under Sections 185 and 186 of the Companies Act, 2013 passed with 100% votes in favour (20,84,646 shares). Mrs. Twinkle Agarwal was appointed as Secretarial Auditor with 100% approval. The scrutinizer's report was issued by CS Jay Arvind Jain of Jay Jain & Associates.
All resolutions passed overwhelmingly, signalling smooth shareholder support. The addition of two independent directors strengthens board independence, while the revised remuneration and lending/investment authority give the management more operational flexibility going forward.